Table 1:
Publication Rates by Year and correlation with Cancer Type
| Cancer Subtypes | Podium Presentations Published within 3 years | p-value | ||
|---|---|---|---|---|
| 2017 | 2018 | 2017–2018 | ||
| OVARIAN | 13 (46.4%) | 17 (54.8%) | 30 (52.6%) | P=0.23 |
| ENDOMETRIAL | 11 (84.6%) | 9 (56.3%) | 20 (69.0%) | P=0.15 |
| CERVICAL | 8 (57.1%) | 6 (46.2%) | 14 (51.9%) | P=0.56 |
| VULVAR | 0 (0%) | 0 (0%) | 0 (0%) | P=0.25 |
| MISC | 11 (57.9%) | 15 (65.2%) | 26 (61.9%) | P=0.45 |
| TOTAL | 43 (57.3%) | 47 (56.6%) | 90 (57.0.%) | |
Podium presentations are subdivided by cancer subtype for the SGO 2017 and 2018 Annual Meetings. Noted above are the podium presentations that were published within 3 years grouped by cancer type. The p-values listed above compare the correlation between the combined cancer subtype and likelihood of publication within 3 years.